 |
|
Upcoming Events featuring
National CooperativeRx
|
|
|
Mid-Sized Retirement & Healthcare Plan Management Conference
March 18-21, 2012
San Francisco, CA
Learn more
AK- National CooperativeRx Annual Member Meeting
March 21-22, 2012
Anchorage, AK
WI- National CooperativeRx Annual Member Meeting
April 25, 2012
Madison, WI
Mid-Sized Retirement & Healthcare Plan Management Conference
June 5-8, 2012
Chicago, IL
Learn more
|
|
 |
National CooperativeRx is a not-for-profit coalition founded and owned by plan sponsors to achieve higher value prescription benefits through volume purchasing, clinical solutions, actionable data and unparalleled customer service. For your sales and marketing needs, please contact us at 866-679-9479, extension 223
|
|
|
Upcoming National CooperativeRx Member MeetingsThe National CooperativeRx Annual Member Meetings are approaching quickly! - March 21-22: National CooperativeRx Annual Member Meeting in Anchorage, AK
- April 25: National CooperativeRx Annual Member Meeting in Madison, WI
National CooperativeRx is looking forward to our Annual Member Meeting next week in Anchorage, AK! The meeting in Madison will take place next month, and we have some great speakers lined up for our members. For a sneak peak of our keynote speaker for both meetings, click here to watch a short clip as Mr. Kim Slocum discusses the average American health care consumer.
|
|
Washington Post. A skyrocketing increase in the off-label use of atypical anti-psychotics is alarming medical experts. Meant for patients with disabling mental illnesses such as schizophrenia, this article outlines how they are being prescribed for everything from students with insomnia to small children with behavior problems. (Boodman, 3/12) Full story
|
Fox News. A recent study has suggested another health benefit of taking statins: they may lower a person's risk of developing Parkinson's disease. Over a 12 year study, people under 60 who took cholesterol-lowering statins had a 69% lower risk of developing the disease. More studies are needed to verify that the results are not just chance and whether the results hold true for all statins. (Rettner, 3/13) Full story
|
|
Philadelphia Inquirer. Should doctors dispense medications? In a growing trend, more doctors are. On the upside, it's convenient for patients, it improves adherence, and it encourages generics because physicians become more aware of cost. On the downside, there is more potential for conflict of interest, and pharmacists who could detect prescribing errors are removed from being able to do so. (3/13) Full story
|
|
R&D Magazine. Manufacturing prescription drugs involves synthesizing active ingredients and shipping them to another site where they're converted into large batches of pills. The Massachusetts Institute of Technology (MIT) has teamed up with Novartis to create a continuous manufacturing process, which could all be done at one location and cut down on both time and cost. (Trafton, 3/14) Full story
|
|
Red Orbit. The government in India has ended Bayer's monopoly on Nexavar, a patented cancer drug. India's Patent Act states that a generic version of a patented drug can be created if the current drug is "not available to the public at a reasonably affordable price." Nexavar sells for $5,600 per month in India, and the generic will cost $176. Although generics that break patents are required to pay the patent-holder 6% of earnings and can't break the patent for the first 3 years, it could set a precedent for future patents to be broken. (Red Orbit, 3/13) Full story
|
|
Drug Topics. The increasing problem of drug shortages supports legislation that would require drug manufacturers to notify the FDA of upcoming issues. Manufacturers blame policies that limit production of controlled substances for the shortages, while regulators blame brand-name manufacturers for the shortages in an effort to build sales of more expensive medications. (Wechsler, 3/15) Full story
|
|
 |
|
